MedTrace Logo

CREATION Health Readmission Risk Assessment Tool

NCT03424382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1218

Last updated 2020-02-07

No results posted yet for this study

Summary

This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrument refinement. Phase 2 involves administering the refined instrument to a new group of patients to determine final item content for the instrument, its factor structure, and its predictive validity.

Conditions

Sponsors & Collaborators

  • AdventHealth

    lead OTHER

Principal Investigators

  • Patricia Robinson · Center for CREATION Health Research

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-12-05
Completion
2019-11-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424382 on ClinicalTrials.gov